Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Insulet Corporation (PODD) PT Raised to $58 at Jefferies
August 4, 2017 8:38 AM EDTJefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a Buy rating following the company's 2Q conference call.
The company provided more detail on the plans it announced on July 20 to abandon its distributor Ypsomed and go... More
Insulet Corporation (PODD) PT Raised to $63 at Cowen on 2Q Report; 'Direct Europe Commercialization Drives Sharp Upward Estimate Revisions'
August 4, 2017 6:42 AM EDTCowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $63.00 (from $52.00) while maintaining a Outperform rating, following the company's second quarter earnings report.
Analyst Doug Schenkel notes the company delivered second quarter revenues above consensus projections, despite offering earnings per share results below... More
